These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36321820)

  • 1. Clinical Performance of Three Commercial Molecular Diagnostic Assays for the Detection of Fluoroquinolone Resistance-Associated Mutations in Mycoplasma genitalium.
    Gardette M; Hénin N; Le Roy C; Guiraud J; Touati A; Bébéar C; Pereyre S
    J Clin Microbiol; 2022 Dec; 60(12):e0113522. PubMed ID: 36321820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of markers predictive of macrolide and fluoroquinolone resistance in
    Day MJ; Cole MJ; Fifer H; Woodford N; Pitt R
    Sex Transm Infect; 2022 May; 98(3):215-218. PubMed ID: 34088790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrolide and fluoroquinolone associated mutations in Mycoplasma genitalium in a retrospective study of male and female patients seeking care at a STI Clinic in Guangzhou, China, 2016-2018.
    Ke W; Li D; Tso LS; Wei R; Lan Y; Chen Z; Zhang X; Wang L; Liang C; Liao Y; Chen H; Liu Y; Zheng H; Yang L
    BMC Infect Dis; 2020 Dec; 20(1):950. PubMed ID: 33308173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Evaluation of Three Commercial PCR Assays for the Detection of Macrolide Resistance in Mycoplasma genitalium.
    Le Roy C; Bébéar C; Pereyre S
    J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31801835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance.
    Couldwell DL; Tagg KA; Jeoffreys NJ; Gilbert GL
    Int J STD AIDS; 2013 Oct; 24(10):822-8. PubMed ID: 24052013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter Clinical Evaluation of a Novel Multiplex Real-Time PCR (qPCR) Assay for Detection of Fluoroquinolone Resistance in Mycoplasma genitalium.
    Fernández-Huerta M; Bodiyabadu K; Esperalba J; Bradshaw CS; Serra-Pladevall J; Garland SM; Fernández-Naval C; Jensen JS; Pumarola T; Ebeyan S; Lundgren M; Tan LY; Espasa M; Murray GL
    J Clin Microbiol; 2019 Nov; 57(11):. PubMed ID: 31434719
    [No Abstract]   [Full Text] [Related]  

  • 7. Remarkable increase in fluoroquinolone-resistant Mycoplasma genitalium in Japan.
    Kikuchi M; Ito S; Yasuda M; Tsuchiya T; Hatazaki K; Takanashi M; Ezaki T; Deguchi T
    J Antimicrob Chemother; 2014 Sep; 69(9):2376-82. PubMed ID: 24894419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysis.
    Machalek DA; Tao Y; Shilling H; Jensen JS; Unemo M; Murray G; Chow EPF; Low N; Garland SM; Vodstrcil LA; Fairley CK; Hocking JS; Zhang L; Bradshaw CS
    Lancet Infect Dis; 2020 Nov; 20(11):1302-1314. PubMed ID: 32622378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of Three Commercial Molecular Diagnostic Assays for the Simultaneous Detection of Mycoplasma genitalium and Macrolide Resistance.
    Le Roy C; Bébéar C; Pereyre S
    J Clin Microbiol; 2021 May; 59(6):. PubMed ID: 33731412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of markers predictive of macrolide and fluoroquinolone resistance in
    Pitt R; Fifer H; Woodford N; Alexander S
    Sex Transm Infect; 2018 Feb; 94(1):9-13. PubMed ID: 28717051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of TIB Molbiol LightMix® assays for detection of Mycoplasma genitalium and key resistance mutations for macrolides and fluoroquinolones.
    Balgovind P; Atchison S; Danielewski J; Garland SM; Costa AM; Bodiyabadu K; Murray GL
    Lett Appl Microbiol; 2023 Nov; 76(11):. PubMed ID: 37881107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of macrolide and fluoroquinolone resistance-associated 23S rRNA and parC mutations in Mycoplasma genitalium by nested real-time PCR.
    He W; Yuan Y; Liang J; Fan X; Li L; Pan X
    Front Cell Infect Microbiol; 2023; 13():1271392. PubMed ID: 37928183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoroquinolone and macrolide resistance-associated mutations in Mycoplasma genitalium.
    Tagg KA; Jeoffreys NJ; Couldwell DL; Donald JA; Gilbert GL
    J Clin Microbiol; 2013 Jul; 51(7):2245-9. PubMed ID: 23658265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrolide and fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in Johannesburg, South Africa, 2007-2014.
    Muller EE; Mahlangu MP; Lewis DA; Kularatne RS
    BMC Infect Dis; 2019 Feb; 19(1):148. PubMed ID: 30760230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel probe-based melting curve assays for the characterization of fluoroquinolone resistance in Mycoplasma genitalium.
    Tickner JA; Bradshaw CS; Murray GL; Whiley DM; Sweeney EL
    J Antimicrob Chemother; 2022 May; 77(6):1592-1599. PubMed ID: 35352120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of
    Chua TP; Bodiyabadu K; Machalek DA; Garland SM; Bradshaw CS; Plummer EL; Danielewski J; Vodstrcil LA; Doyle ML; Murray GL
    J Med Microbiol; 2021 Sep; 70(9):. PubMed ID: 34590993
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevalence of
    Wang L; Li Z; Wan C; Tian X; Liu H; Li Y
    Int J STD AIDS; 2023 Jul; 34(8):518-524. PubMed ID: 36929876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of macrolide and fluoroquinolone resistance-mediating mutations in Mycoplasma genitalium in five cities in Russia and Estonia.
    Shipitsyna E; Rumyantseva T; Golparian D; Khayrullina G; Lagos AC; Edelstein I; Joers K; Jensen JS; Savicheva A; Rudneva N; Sukhanova L; Kozlov R; Guschin A; Unemo M
    PLoS One; 2017; 12(4):e0175763. PubMed ID: 28407014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Mycoplasma genitalium and mutations associated with macrolide and fluoroquinolone resistance in Finland.
    Hokynar K; Hiltunen-Back E; Mannonen L; Puolakkainen M
    Int J STD AIDS; 2018 Aug; 29(9):904-907. PubMed ID: 29631509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of macrolide and fluoroquinolone resistance-associated mutations in
    Pereyre S; Laurier-Nadalié C; Le Roy C; Guiraud J; Dolzy A; Hénin N; Gardette M; Bébéar C;
    Sex Transm Infect; 2023 Jun; 99(4):254-260. PubMed ID: 36413349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.